9 May 2024 Pharmaceuticals Psoriatic Athritis Spondyloarthritis TGA approves bimekizumab for PsA and axSpA
9 November 2023 Anti JAKS Dermatology Plaque psoriasis Psoriatic Athritis Anti-JAKs safe in skin conditions
26 October 2023 Axial spondyloarthritis Plaque psoriasis Psoriatic Athritis New kid on the spondyloarthritis block shows sustained benefit
12 October 2023 Mental Health Psoriatic Athritis Rheumatoid Arthritis Simple anxiety screening tool success
21 September 2023 Patient Perspective Plaque psoriasis Psoriatic Athritis Psoriasis management resources to empower your patients
24 April 2023 Lupus Osteoporosis PBAC Plaque psoriasis Psoriatic Athritis Anifrolumab decision headlines PBAC outcomes
13 April 2023 Axial spondyloarthritis Psoriatic Athritis TNF Tapering: a pyrrhic exercise or something worthwhile?
16 March 2023 Medications Plaque psoriasis Psoriatic Athritis IL-23 inhibitors for psoriasis best at preventing arthritis development
9 March 2023 Anti JAKS Psoriatic Athritis Rheumatoid Arthritis More real-world reassurance for JAKi and cancer
26 April 2022 Lupus PBS Psoriatic Athritis Scleroderma Spondyloarthritis PBS biologics approval shakeup on the way
5 August 2021 Pharmacy Guild of Australia Psoriatic Athritis Spondyloarthritis Tocilizumab shortage: clinical management advice
